What the evidence actually shows
Public fear of HRT rose after early WHI reporting. Later analyses and modern lower-dose regimens show a more nuanced picture: absolute risk increases for breast cancer with combined therapy are typically small for many midlife women, especially with shorter or carefully monitored use, while untreated severe symptoms also carry quality-of-life and sometimes health costs.
Who needs extra caution
Personal history of hormone-sensitive breast cancer, certain genetic risks, and some unexplained bleeding situations require specialist-aligned decisions. Prior cancer does not always mean “never any hormone” — local vaginal estrogen may still be discussed in select cases with oncology input.
How HormoneFit approaches the conversation
We review history, screening status, and goals, then compare HRT vs non-hormonal options. Read Is HRT safe? or book with HormoneFit.